MENU
+Compare
CNVVY
Stock ticker: OTC
AS OF
Sep 5 closing price
Price
$12.96
Change
+$0.06 (+0.47%)
Capitalization
6.53B

CNVVY ConvaTec Group plc Forecast, Technical & Fundamental Analysis

Originally spun out of Bristol-Myers Squibb, ConvaTec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings... Show more

CNVVY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CNVVY with price predictions
Sep 05, 2025

CNVVY's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for CNVVY turned positive on August 08, 2025. Looking at past instances where CNVVY's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CNVVY advanced for three days, in of 105 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 246 cases where CNVVY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 04, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CNVVY as a result. In of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CNVVY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CNVVY broke above its upper Bollinger Band on August 20, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.636) is normal, around the industry mean (11.022). P/E Ratio (30.566) is within average values for comparable stocks, (59.569). Projected Growth (PEG Ratio) (1.635) is also within normal values, averaging (1.744). Dividend Yield (0.021) settles around the average of (0.016) among similar stocks. P/S Ratio (2.826) is also within normal values, averaging (12.728).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CNVVY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
CNVVY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published Dividends

CNVVY is expected to pay dividends on October 16, 2025

ConvaTec Group plc CNVVY Stock Dividends
A dividend of $0.07 per share will be paid with a record date of October 16, 2025, and an ex-dividend date of August 22, 2025. The last dividend of $0.18 was paid on June 12. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
20 Eastbourne Terrace
Phone
+44 7826447807
Employees
10129
Web
https://www.convatecgroup.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
HELX30.620.36
+1.20%
Franklin Genomic Advancements ETF
PIZ46.310.33
+0.72%
Invesco DW Developed Markets Momt ETF
ERH11.970.04
+0.30%
Allspring Utilities and High Income Fund
CPNQ25.920.01
+0.06%
Calamos Nasdaq-100 Str Alt Prt ETF-Dec
ILCG100.31-0.36
-0.35%
iShares Morningstar Growth ETF

CNVVY and Stocks

Correlation & Price change

A.I.dvisor tells us that CNVVY and ALGN have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CNVVY and ALGN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNVVY
1D Price
Change %
CNVVY100%
+0.47%
ALGN - CNVVY
27%
Poorly correlated
+3.28%
SGHT - CNVVY
25%
Poorly correlated
-1.07%
RVTY - CNVVY
24%
Poorly correlated
+1.10%
KIDS - CNVVY
22%
Poorly correlated
+0.97%
CRL - CNVVY
21%
Poorly correlated
+1.04%
More

Groups containing CNVVY

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNVVY
1D Price
Change %
CNVVY100%
+0.47%
Pharmaceuticals: Other
industry (103 stocks)
15%
Poorly correlated
+0.58%
Pharmaceuticals
industry (387 stocks)
13%
Poorly correlated
+1.69%